Found 11 matching trials
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma
PHASE1Laboratory studies suggest that the study drug may stop cancer cells from g...
Location
USC Norris Comprehensive Cancer Center
Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer
PHASE2This randomized phase II trial studies how well combination chemotherapy an...
Location
USC Norris Comprehensive Cancer Center
A Follow-up Evaluation Study of PRI-724-1101
N/AThe purpose of this study To evaluate the safety and efficacy of PRI-724 ad...
Location
Tokyo metropolitan Komagome Hospital
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
PHASE1To evaluate the safety and pharmacokinetics of OP-724 and to determine the ...
Location
Tokyo Metropolitan Komagome Hospital
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors
PHASE1PRI-724 is a new investigational drug being studied to treat subjects with ...
Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies
PHASE1PRI-724 is a new investigational drug being studied to treat subjects with ...
Location
Emory University / Winship Cancer Institute
An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis
PHASE1The purpose of this study is to investigate the safety and tolerability of ...
Location
Tokyo metropolitan Komagome Hospital
A Phase 2 Trial of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia (OP-724-H201)
PHASE2This is a phase 2 trial of foscenvivint in liver cirrhosis patients caused ...
Location
Hokkaido University Hospital
A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
PHASE2This is a phase 2 study to evaluate the efficacy and safety of foscenvivint...
Location
Hokkaido University Hospital
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
PHASE1To investigate the safety and efficacy of PRI-724 against HCV or HBV liver ...
Location
Kohnodai Hospital, National Center for Global Health and Medicine